Research Progress of Acquired Resistance Mediated by MET Amplification 
in Advanced Non-small Cell Lung Cancer

Research Progress of Acquired Resistance Mediated by MET Amplification 
in Advanced Non-small Cell Lung Cancer

Mesenchymal-epithelial transition factor (MET) amplification is an important driver of resistance in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), and the combination of MET proto-oncogene (MET) and EGFR-tyrosine kinase inhibitors (TKIs) has shown promise in over...

Full description

Bibliographic Details
Main Authors: Sisi PAN, Na WANG, Xia SONG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2022-08-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
targeted therapy
met amplification
acquired resistance
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.23

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.23

Similar Items